Registered entities
Adaptive Biotechnologies Corp
Reg. No. 1478320United States
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Reg. No. 270907024Belgium
Innovation
59 patent families (40 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace steady. Cited 62,897 times.
| Year | Filings |
|---|---|
| 2015 | 18 |
| 2016 | 30 |
| 2017 | 20 |
| 2018 | 22 |
| 2019 | 17 |
| 2020 | 13 |
| 2021 | 12 |
| 2022 | 11 |
| 2023 | 9 |
| 2024 | 12 |
| 2025 | 15 |
| 2026 | 4 |
Social engagement
Social engagement: 34.1K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
23 investors on record; lead investors include Viking Global Investors, Matrix; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 43% |
| Private equity | 3 | 13% |
| Bank & private debt | 1 | 4% |
| Other / undisclosed | 9 | 39% |
Hiring activity
Hires periodically
8 roles tracked across 4 of the last 12 months
5 Feb 2026 · Senior Talent Acquisition Partner (Temporary) · Seattle
24 Jan 2026 · Material Handler II · Seattle
21 Dec 2025 · Software Engineer III (Camunda Engineer) · Seattle
5 Dec 2025 · Senior Network Engineer · Seattle
23 Nov 2025 · HR Generalist · Seattle
Based on job postings tracked across public sources.
Recent activity
30 Jun 2026
Milestone
regulatory
9 Jun 2026
Partnership
OpenFold Consortium
29 May 2026
Event
ASCO2026 and EHA2026